NEW YORK (GenomeWeb News) – The molecular diagnostics firm Micronics has reeled in two grants from the National Institute of Allergy and Infectious Diseases totaling $1.2 million to develop nucleic-acid based diagnostic tests, the company said today.

Under one grant, the company will develop a test for mother-to-child-transmission (MTCT) of the human immunodeficiency virus, and it will use another to develop a test for known and emerging respiratory infections.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.